TELISOTUZUMAB
UNII R15ZW356HN

Substance Identification & Data

This profile provides standardized clinical and technical data for Telisotuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) R15ZW356HN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1781223-80-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
R15ZW356HN
CAS Registry Number
1781223-80-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TELISOTUZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10366
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
EF-52
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Telisotuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TELISOTUZUMAB

Common Names & Synonyms

HUMANIZED IGG1 ANTI-C-MET ANTIBODY
TELISOTUZUMAB [INN]
TELISOTUZUMAB [USAN]
TELISOTUZUMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN HEPATOCYTE GROWTH FACTOR RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL ABT-700 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL ABT-700 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN HEPATOCYTE GROWTH FACTOR RECEPTOR (HGF RECEPTOR, PROTO-ONCOGENE C-MET, SCATTER FACTOR RECEPTOR, TYROSINE-PROTEIN KINASE MET, EC=2.7.10.1))

Technical Codes

ABT-700